MAPK3 and allergic asthma: However, we and others have previously identified the EGFR, ERK1/2 and AKT to be an important signaling pathway in the development of pathophysiological changes in the murine allergic asthma model and is indeed susceptible to inhibition by OBE treatment (Takeyama et al.